Anthony M. McElligott

A new microtubule-targeting compound PBOX-15 inhibits T-cell migration via post-translational modifications of tubulin

Navin Kumar Verma, Eugene Dempsey, Jennifer Conroy et al. · Journal of Molecular Medicine · 2008 · 36 citations

Post-translational Modifications, T-regulatory Cell, Immunology +8

Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia

Stephen E. Langabeer, Fiona Quinn, David O’Brien et al. · Leukemia Research · 2012 · 33 citations

Hematological Malignancy, Immunohematology, Lymphoid Neoplasia +13

The Novel Tubulin-Targeting Agent Pyrrolo-1,5-Benzoxazepine-15 Induces Apoptosis in Poor Prognostic Subgroups of Chronic Lymphocytic Leukemia

Anthony M. McElligott, Elaina N. Maginn, Lisa M. Greene et al. · Cancer Research · 2009 · 32 citations · Full text

Selective detection of UCP 3 expression in skeletal muscle: effect of thyroid status and temperature acclimation

Orla Cunningham, Anthony M. McElligott, Audrey M. Carroll et al. · Biochimica et Biophysica Acta (BBA) - Bioenergetics · 2003 · 30 citations

Muscle Function, Signal Transduction, Biochemistry +10

PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells

Elaina N. Maginn, Paul Browne, Patrick Hayden et al. · British Journal of Cancer · 2010 · 29 citations · Full text